Publication | Open Access

Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease

Medicinal ChemistryBiochemistryMedicineNatural SciencesNovel Cannabidiol−carbamate HybridsPharmacologySelective Buche InhibitorsDrug DevelopmentChemical BiologyMolecular DockingDrug DiscoveryDocking-based Fragment Reassembly